News
The following is a summary of “Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension,” ...
A new blood pressure medication called lorundrostat has shown promising results in reducing blood pressure among patients ...
Perspectives from Keith Churchwell, MD, FAHA Keith C. Ferdinand, MD CHICAGO — The investigational aldosterone synthase inhibitor lorundrostat effectively lowered 24-hour BP for adults with well ...
Lorundrostat is in a new class of blood pressure medications called aldosterone synthase inhibitors (ASIs). Several ASIs are currently in development and are designed to work by disrupting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results